Remicade® (infliximab) has now been approved to treat Crohn’s Disease and Ulcerative Colitis. Crohn’s disease is a chronic inflammatory disease of the gastrointestinal (GI) tract. It generally affects over 500,000 Americans. Remicade® can help reduce the symptoms of Crohn’s Disease and is FDA-approved to block TNF-alpha, which can be a cause of the inflammation. Ulcerative Colitis is a condition with similar symptoms to Crohn’s Disease. Remicade® can also help reduce the symptoms and signs of Ulcerative Colitis while also healing damage to the lining of your intestines.
Results will vary from patient to patient, depending on the severity of the condition. We can administer Remicade® through an infusion right in our Remicade Clinic. Please feel free to contact us if you have any questions.